Our study is the first to demonstrate that ALDH2 expression is downregulated in PC, while high ALDH2 expression is associated with an earlier stage, a lower pathologic grade, and a better prognosis in PC patients. This evidence concerns the gene ALDH2 and pachyonychia congenita.